Disclosure Index · GLP-1 · Weight management

MEDVi

3 of 6 key facts published on MEDVi's own website. Checked Nov 1, 2026. Not a rating of care quality.

Before you pay

What MEDVi tells you up front

From MEDVi's public pages and the FDA warning-letter database.

✓
What will I actually pay?Answered on their site

Compounded semaglutide advertised at $99 for the first month, with refills "locked in at $199." Tablets start at $249; brand-name options are a $99 membership plus medication cost.

✓
What if I'm not approved?Answered on their site

Refund policy published: full refund if you cancel within 72 hours and haven't received services, or if a clinician disqualifies you. No refund for the current or earlier months on monthly plans. Two clauses on the same page contradict each other.

½
Who fills my prescription?Partly answered

Names partner pharmacies with addresses (Triad Rx, RedRock Pharmacy, Beaker Pharmacy & Compounding) but not which one fills your order.

½
Who reviews my case?Partly answered

Names the medical groups (OpenLoop Health and CareGLP Affiliated P.C.s), not individual clinicians.

✓
How do I cancel?Answered on their site

Email hello@medvi.org or use the patient-portal chat at least 72 hours before your next billing date.

!
Any FDA warning letters?Yes

FDA warning letter #721455 dated Feb 20, 2026, addressed to MEDVi, LLC, citing false or misleading claims about compounded GLP-1s on medvi.io. MEDVi says that site belonged to an affiliate marketer. Read the letter ↗

?
Do they serve my state?Ask before you pay

“Do you serve my state, and does my state require a live visit?” Not found on the pages we reviewed. MEDVi's terms say service is only available in certain states and send you to customer support for the list.

Run MEDVi? Publish the missing information on your site, then request a re-check →

The pages behind every answer

home.medvi.org/↗glp1.medvi.org/↗home.medvi.org/cancellation-and-refund-policy↗home.medvi.org/terms-and-conditions↗www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medvi-llc-dba-medvi-721455-02202026↗